Looking to find the perfect combination of strengths in KOLs and online influencers? Our latest blog post uncovers the secrets of multi-layered, segmented influencer lists. Stay tuned for expert insights! #KOL#MedAffairs#PharmaMarketing#MedTech https://t.co/8VDFRvfxGl
@tapshah21 Hi Tapan! Yesterday my app stopped returning user data when calling the X ID user endpoint. Nothing in the documentation implies that was intentionally deprecated; can you please help?
@chrisparkX Chris, can you help me out? My app that makes API calls for user data based on Twitter ID stopped working yesterday. Documentation still says that should work w/my basic plan. Any ideas?
@XDevelopers It appears that you've changed the API endpoints for USER queries from the basic subscription. Can you confirm? That's not anywhere in the documentation.
2/2 But July, August and September of 2024 were each significantly higher than the same months in 2023. I'm encouraged that doctors are coming back. We'll keep watching! #MedTwitter#HCSM#HCSMEU
Interesting #MedTwitter stats: Comparing monthly twitter posts from global doctors, Posts from January-June of 2023 and 2024, physician posts were slightly down (February was actually up 2%). 1/2
The Bluebird layoffs this week "offered another reminder that groundbreaking genetic medicines capable of transforming the lives of people with inherited disease are not now — and may never become — a sustainable business."
via @adamfeuerstein https://t.co/VnEOWPJM5j
Did you ever wonder if cardiologists around the world are still active on X/Twitter? They are. Contact us at [email protected] for more information! https://t.co/cuzjccRkhH
PBMs are supposed to be the superheroes fighting high drug prices, but perverse incentives often make actual low prices their kryptonite.
Kudos to @RebeccaDRobbins@ReedAbelson for a complete undressing of our dysfunctional prescription drug marketplace. https://t.co/rHOM16AShW
This one absolutely does NOT pass the sniff test - rest assured that we'll be doing some fact-checking!! | Many docs who tweeted product endorsements also took money from manufacturers, analysis shows | by @pharmalot https://t.co/FTXZhFZswH